Charles Bennett to Breast Neoplasms
This is a "connection" page, showing publications Charles Bennett has written about Breast Neoplasms.
Connection Strength
1.477
-
Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer. Breast Cancer Res Treat. 2016 05; 157(1):193-200.
Score: 0.265
-
Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment. JAMA Oncol. 2016 Feb; 2(2):274-6.
Score: 0.261
-
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program. Breast Cancer Res Treat. 2013 Jan; 137(2):589-98.
Score: 0.210
-
Acting on imperfect evidence: How much regret are we ready to accept? J Clin Oncol. 2005 Oct 01; 23(28):6822-5.
Score: 0.127
-
The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004 May-Jun; 2(3):271-8.
Score: 0.115
-
Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg. 2001 Apr; 233(4):537-41.
Score: 0.093
-
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 06; 13(6):e562-e573.
Score: 0.071
-
Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model. Maturitas. 2017 Jan; 95:42-49.
Score: 0.068
-
Relationship of Industry Sponsorship to Results of Cost-Effectiveness Analyses of Drugs Used in Breast Cancer Treatment--Reply. JAMA Oncol. 2016 Apr; 2(4):549.
Score: 0.066
-
Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016 Jan; 155(1):3-12.
Score: 0.065
-
Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). 2015 Apr; 24(4):291-8.
Score: 0.061
-
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. 2007 Feb 07; 99(3):196-205.
Score: 0.035
-
Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol. 2004 Jun 15; 22(12):2430-7.
Score: 0.029
-
Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clin Cancer Res. 2011 Feb 01; 17(3):560-8.
Score: 0.012